Shopping Cart
- Remove All
- Your shopping cart is currently empty
Eltanexor (ONO-7706) is an orally active exportin-1 (XPO1) inhibitor. It has effective anti-leukemic activity. Eltanexor inhibits XPO1-dependent nuclear export (EC50=60.9 nM) by directly targeting XPO1. Eltanexor causes caspase-dependent apoptosis in a panel of leukemic cell lines.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $60 | In Stock | |
2 mg | $108 | In Stock | |
5 mg | $237 | In Stock | |
10 mg | $282 | In Stock | |
25 mg | $466 | In Stock | |
50 mg | $662 | In Stock | |
100 mg | $959 | In Stock | |
500 mg | $1,920 | In Stock | |
1 mL x 10 mM (in DMSO) | $223 | In Stock |
Description | Eltanexor (ONO-7706) is an orally active exportin-1 (XPO1) inhibitor. It has effective anti-leukemic activity. Eltanexor inhibits XPO1-dependent nuclear export (EC50=60.9 nM) by directly targeting XPO1. Eltanexor causes caspase-dependent apoptosis in a panel of leukemic cell lines. |
Targets&IC50 | XPO1:60.9 nM(EC50) |
In vitro | Eltanexor (KPT-8602) (1 nM; 16 hours) causes apoptosis in leukemia cell lines. KPT-8602 (2-6 nM; 72 hours) decreases cell viability in leukemia cell lines (EC50s ranging from 25 to 145 nM). |
In vivo | KPT-8602 (15 mg/kg; oral gavage; daily for 12 days) demonstrates potent anti-lymphoblastic leukemia activity. |
Alias | ONO-7706, KPT-8602, ATG-016 |
Molecular Weight | 428.29 |
Formula | C17H10F6N6O |
Cas No. | 1642300-52-4 |
Smiles | NC(=O)C(=C\n1cnc(n1)-c1cc(cc(c1)C(F)(F)F)C(F)(F)F)\c1cncnc1 |
Relative Density. | 1.57 g/cm3 (Predicted) |
Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (186.78 mM) H2O: < 0.1 mg/mL (insoluble) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.